TY  - CHAP
M1  - Book, Section
TI  - Paraneoplastic Neurologic Syndromes and Autoimmune Encephalitis
A1  - Dalmau, Josep
A1  - Rosenfeld, Myrna R.
A2  - Jameson, J. Larry
A2  - Fauci, Anthony S.
A2  - Kasper, Dennis L.
A2  - Hauser, Stephen L.
A2  - Longo, Dan L.
A2  - Loscalzo, Joseph
Y1  - 2018
N1  - 
T2  - Harrison's Principles of Internal Medicine, 20e
AB  - Paraneoplastic  neurologic  disorders  (PNDs)  are  cancer-related  syndromes  that  can  affect  any  part  of  the  nervous  system  (Table  90-1).  They  are  caused  by  mechanisms  other  than  metastasis  or  by  any  of  the  complications  of  cancer  such  as  coagulopathy,  stroke,  metabolic  and  nutritional  conditions,  infections,  and  side  effects  of  cancer  therapy.  In  60%  of  patients,  the  neurologic  symptoms  precede  the  cancer  diagnosis.  Clinically  disabling  PNDs  occur  in  0.5–1%  of  all  cancer  patients,  but  they  affect  2–3%  of  patients  with  neuroblastoma  or  small-cell  lung  cancer  (SCLC)  and  30–50%  of  patients  with  thymoma.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1180554522
ER  -